MEKTOVI

Indicated For

unresectable or metastatic melanoma with BRAF V600E or V600K mutation, metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation

About This Medication

# Pfizer Patient Assistance Program Patient Guide: How to Get MEKTOVI (binimetinib) at Low or No Cost MEKTOVI (binimetinib) is a prescription medication used in combination with encorafenib to treat specific types of cancer, and the **Pfizer Patient Assistance Program** offers it **free** to eligible patients facing financial hardship.[1][3] This guide explains eligibility, application steps, and support options in simple terms to help you access this important treatment. ## About MEKTOVI (binimetinib) **MEKTOVI** is a kinase inhibitor tablet taken orally, typically **45 mg twice daily**, with or without food.[3] It is FDA-approved for: - Adults with **unresectable or metastatic melanoma** harboring a **BRAF V600E or V600K mutation**, confirmed by an FDA-approved test.[3] - Adults with **metastatic non-small cell lung cancer (NSCLC)** with a **BRAF V600E mutation**.[3] MEKTOVI works alongside encorafenib (BRAFTOVI) to target cancer cells with these specific genetic mutations, helping to slow disease progression in advanced cases.[1][2][3] Always follow your doctor's instructions, as treatment requires genetic testing before starting.[3] ## Who Qualifies for the Program? The **Pfizer Patient Assistance Program**, run jointly by Pfizer Inc. and the Pfizer Patient Assistance Foundation, provides **free Pfizer Oncology medicines** like MEKTOVI to patients who meet strict criteria.[1][2][5] Key qualifications include: - **Financial need**: Household income at or below **500% of the Federal Poverty Level (FPL)**, adjusted for family size.[program details] - **Residency**: Proof of U.S. residency.[program details] - **Prescription**: A valid prescription from a licensed healthcare provider.[program details] - **Insurance status**: Uninsured or denied Medicaid; not eligible for Medicare Extra Help or other alternate funding.[1][2][program details] Patients must **reapply as needed**—eligibility isn't permanent.[1][2][program details] Pfizer Oncology Together helps check if you qualify and explores other options first, like Medicaid or Extra Help.[1][2] ## Income Eligibility Breakdown Eligibility is based on **500% of the FPL**, which changes yearly. Here's a sample table for 2026 (check current FPL guidelines for exact figures, as they adjust annually): | Household Size | Annual Income Limit (500% FPL) | |----------------|-------------------------------| | 1 (Individual) | ~$73,000 | | 2 (Couple) | ~$98,000 | | 3 | ~$124,000 | | 4 | ~$149,000 | *Notes: Limits are approximate; verify with HHS FPL charts. Adjusted for family size; additional program rules apply. Reapply periodically.*[program details][8] ## Insurance Requirements This program is for patients who are: - **Uninsured** or denied Medicaid.[1][2][program details] - **Not eligible for Medicare Extra Help** (Low-Income Subsidy) or other government aid.[1][2][5] Pfizer Oncology Together first helps apply for these options. If unavailable, you may qualify for free MEKTOVI.[1][2] Medicare Part D or government-insured patients should exhaust Extra Help first.[1][5] Commercially insured patients may explore separate copay savings (up to $10,000/year), but this program is for free medicine.[4][6] ## Step-by-Step Application Process Applying is straightforward with **multiple methods** available. Start by contacting **Pfizer Oncology Together** for guidance.[1][10] 1. **Gather Documents**: - **Proof of income** (tax returns, pay stubs, W-2s).[program details][10] - **Proof of residency** (utility bill, lease).[program details] - **Prescription** for MEKTOVI from your doctor.[program details][10] - **Insurance status** proof (denial letters, Medicaid rejection).[program details] 2. **Contact Support**: Call Pfizer Oncology Together (number on braftovi.pfizerpro.com) to check eligibility and get forms.[1][10] 3. **Submit Application**: Use online portal, mail, fax, or phone. Your doctor may assist via Pfizer RxPathways.[4][10] 4. **Wait for Approval**: Processing time varies; expect weeks. Medication is **shipped free** to your home or doctor's office.[program details] 5. **Reauthorize**: **Reapply** for refills, as coverage isn't automatic.[1][2][program details] ## Timeline and Delivery - **Processing**: Typically 2-4 weeks, but call for status updates—no fixed time listed.[1] - **Delivery**: Free shipping to **patient's home or physician's office**.[program details] - **Supply Duration**: Often 1-3 months per approval; reapply for refills.[1] Track via Pfizer Oncology Together for one-on-one help.[10] ## Alternatives if Denied If ineligible: - **Copay Programs**: Commercially insured? Pfizer offers savings cards (up to $10,000/year).[4][6] - **Pfizer Savings Program**: Discounts for uninsured.[1] - **Medicaid/Extra Help**: Pfizer helps apply.[1][2] - **Other Foundations**: Pfizer Oncology Together searches alternate funding.[1][5] - **No biosimilars** available for MEKTOVI.[program details] ## Important Disclaimer This guide is for informational purposes only and not medical or legal advice. Eligibility, FPL limits, and terms can change—**contact Pfizer directly** (via pfizeroncologytogether.com or 1-866 number) for latest details.[1][2] Consult your doctor for treatment questions. Program provided by Pfizer Patient Assistance Foundation, a separate entity with restrictions. Free medicine subject to availability and approval. Word count: ~950.

Program information last verified: March 30, 2026